Morgan Stanley Cuts Vitamin Shoppe (VSI) Price Target to $3.75
Vitamin Shoppe (NYSE:VSI) had its target price cut by Morgan Stanley from $4.00 to $3.75 in a research note issued to investors on Wednesday. They currently have an equal weight rating on the specialty retailer’s stock.
Several other research firms have also recently issued reports on VSI. Barclays dropped their price target on Vitamin Shoppe from $6.00 to $3.00 and set an equal weight rating on the stock in a report on Thursday, November 9th. Zacks Investment Research cut Vitamin Shoppe from a hold rating to a sell rating in a report on Tuesday, November 7th. Finally, ValuEngine cut Vitamin Shoppe from a buy rating to a hold rating in a report on Sunday, December 31st. Four investment analysts have rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the company’s stock. The company has a consensus rating of Hold and a consensus target price of $4.95.
Shares of Vitamin Shoppe (VSI) opened at $4.00 on Wednesday. Vitamin Shoppe has a twelve month low of $2.95 and a twelve month high of $22.70. The company has a market capitalization of $95.91, a P/E ratio of -0.39 and a beta of 0.64. The company has a current ratio of 2.25, a quick ratio of 0.32 and a debt-to-equity ratio of 0.65.
In other news, major shareholder Shah Capital Management bought 300,000 shares of the business’s stock in a transaction on Monday, February 5th. The shares were bought at an average cost of $3.83 per share, with a total value of $1,149,000.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, major shareholder Vintage Capital Management Llc bought 133,804 shares of the business’s stock in a transaction on Tuesday, January 2nd. The shares were purchased at an average cost of $4.28 per share, for a total transaction of $572,681.12. The disclosure for this purchase can be found here. Insiders acquired 1,000,639 shares of company stock worth $4,387,647 in the last ninety days. 1.07% of the stock is owned by corporate insiders.
A number of large investors have recently made changes to their positions in the business. Voya Investment Management LLC raised its stake in Vitamin Shoppe by 7.5% during the 2nd quarter. Voya Investment Management LLC now owns 34,810 shares of the specialty retailer’s stock valued at $406,000 after purchasing an additional 2,414 shares during the period. Dynamic Technology Lab Private Ltd raised its stake in Vitamin Shoppe by 72.7% during the 2nd quarter. Dynamic Technology Lab Private Ltd now owns 17,761 shares of the specialty retailer’s stock valued at $207,000 after purchasing an additional 7,478 shares during the period. UBS Asset Management Americas Inc. raised its stake in Vitamin Shoppe by 17,041.4% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 11,999 shares of the specialty retailer’s stock valued at $140,000 after purchasing an additional 11,929 shares during the period. Pinebridge Investments L.P. raised its stake in Vitamin Shoppe by 28.3% during the 4th quarter. Pinebridge Investments L.P. now owns 63,860 shares of the specialty retailer’s stock valued at $281,000 after purchasing an additional 14,079 shares during the period. Finally, Nationwide Fund Advisors raised its stake in Vitamin Shoppe by 84.3% during the 2nd quarter. Nationwide Fund Advisors now owns 31,662 shares of the specialty retailer’s stock valued at $369,000 after purchasing an additional 14,478 shares during the period. 91.03% of the stock is currently owned by institutional investors.
TRADEMARK VIOLATION NOTICE: This story was posted by Daily Political and is the sole property of of Daily Political. If you are accessing this story on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The legal version of this story can be accessed at https://www.dailypolitical.com/2018/03/03/morgan-stanley-cuts-vitamin-shoppe-vsi-price-target-to-3-75.html.
About Vitamin Shoppe
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.
Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.